机构:[1]Capital Med Univ, Beijing Tongren Hosp, Beijing 100730, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Capital Med Univ, Key Lab Otolaryngol Head & Neck Surg, Minist Educ, Beijing Inst Otolaryngol, Beijing, Peoples R China首都医科大学附属北京同仁医院研究所耳鼻咽喉科研究所[3]Capital Med Univ, Dept Biol Med Engn, Beijing 100069, Peoples R China
Objectives: The primary purpose of this study was to investigate the longitudinal speech performance over 3 years in pediatric users of the Nurotron (R) cochlear implant system. The secondary purpose was to compare the speech performances of younger and older children with cochlear implants (Cis). Methods: The Mandarin Early Speech Perception (MESP), Meaningful Use of Speech Scale (MUSS), and Putonghua Chinese Communicative Development Inventory (PCDI) were used to evaluate speech performance of 22 Mandarin-speaking pediatric Cl users throughout the first 36 months post-implantation. The subjects were grouped according to the age at implantation, i.e., younger CI group (<3 years) and older CI group (>3 years). Results: All the subjects demonstrated improvement in speech performance throughout the first 3 years of implant use with mean scores reaching the maximum performance at 36 months post-implantation. The median categories of MESP increased from 0.23 pre-implantation to 5.57 three years postimplantation. Likewise, the median percentage of MUSS was 5.57% to 73.75%; the median performance of PCDI was 55 to 400 for PCDI-comprehension and 32 to 384 for PCDI-production at the same interval. At nearly all test intervals, the older group performed better than the younger group except 24 months post-implantation, at which the MUSS score of the younger CI group was higher than that of the older CI group. Conclusion: The children with Nurotron (R) Venus (TM) CI system showed considerable gains in speech and language development including tone performance which improved with hearing age. Earlier implantations haven't presented significantly positive performances until 24 months post-implantation in all the tests. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
基金:
capital health research and
development of special from the Beijing Municipal Health Bureau (No. 2011-1017-01), the research special fund for public welfare
industry of health from the Ministry of Health of the People’s
Republic of China (No. 201202001), the promotion grant for highlevel scientific and technological elites in medical science from the
Beijing Municipal Health Bureau (No. 2009-3-29), key projects in
basic and clinical research cooperation funds from Capital Medical
University (No. 12JL12), the capital citizen health program to foster
from Beijing Municipal Science & Technology Commission (No.
Z141100002114033), and National Natural Science Foundation of
China (No. 81200753).
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Beijing 100730, Peoples R China[2]Capital Med Univ, Key Lab Otolaryngol Head & Neck Surg, Minist Educ, Beijing Inst Otolaryngol, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Tongren Hosp, Beijing 100730, Peoples R China[2]Capital Med Univ, Key Lab Otolaryngol Head & Neck Surg, Minist Educ, Beijing Inst Otolaryngol, Beijing, Peoples R China[3]Capital Med Univ, Dept Biol Med Engn, Beijing 100069, Peoples R China[*1]Beijing Inst Otolaryngol, 17 Hou Gou Hu Tong, Beijing 100005, Peoples R China
推荐引用方式(GB/T 7714):
Li Yuling,Dong Ruijuan,Zheng Yan,et al.Speech performance in pediatric users of Nurotron® Venus™ cochlear implants[J].INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY.2015,79(7):1017-1023.doi:10.1016/j.ijporl.2015.04.016.
APA:
Li, Yuling,Dong, Ruijuan,Zheng, Yan,Xu, Tianqiu,Zhong, Yan...&Chen, Xueqing.(2015).Speech performance in pediatric users of Nurotron® Venus™ cochlear implants.INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY,79,(7)
MLA:
Li, Yuling,et al."Speech performance in pediatric users of Nurotron® Venus™ cochlear implants".INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY 79..7(2015):1017-1023